Search PubMed⌕ Search

Biomedical subjects

K Taniguchi

Publications and source records attributed to K Taniguchi.

At least 811 records · Page 45Linked to original sources
PubMed1985

Distribution of arterial blood flow in human hepatic cancer during chemotherapy--examination by short-lived 81mKr.

Using the characteristics of short-lived radioisotope, 81mKr (half-life = 13 seconds), we studied the distribution of arterial blood flow of human hepatic cancers during intra-hepatic arterial chemotherapy. Sixteen patients with primary and metastatic cancer were catheterized into the hepatic artery during operation. 81mKr solution was continuously infused via the hepatic artery with the patient in the supine, upright, right-side down, and left-side down positions. The frontal and right-side images of the liver were taken with a scinticamera. The tumor/nontumor ratio of the hepatic arterial flow in the supine position was more than one in 14 of 15 patients. The patterns of arterial flow distribution of 81mKr in the four positions were compared. In 11 patients the tumor/nontumor ratio of one of the other positions was significantly higher than that of the supine position. We expect that this quantitative measurement will be a good indicator for evaluation of a drug's accessibility to the tumor in the first pass. Moreover, the choice of the most effective position for intra-arterial infusion chemotherapy by this test will be possible to increase the relative amount of drug reaching the tumor. This technique may be applicable mainly to short-term drug infusion.

Adenocarcinoma↗
PubMed1985

Hemodynamic effects of molsidomine on weight sustaining isometric exercise in patients with ischemic heart disease.

Hemodynamic effects of 2 mg of sublingual molsidomine were evaluated in 11 patients with ischemic heart disease using a weight-sustaining isometric exercise (WSIE) that we developed. Left ventricular end diastolic pressure (LVEDP), mean pulmonary pressure, mean systemic arterial pressure (mAP), cardiac index and stroke work index increased significantly during WSIE before and after molsidomine. Although WSIE resulted in a similar rise of mAP before and after molsidomine, the increment value of LVEDP during WSIE was significantly lower after molsidomine. The recovery time to the resting state of all parameters was shorter and the left ventricular function curves showed a leftward deviation with molsidomine. In conclusion, the results suggest that molsidomine will produce a preload reduction and improve the left ventricular function during WSIE in patients with ischemic heart disease.

Adult↗
PubMed1985

Effects of immunization of mothers on the immune reaction of their offspring. II. Significance of enhanced antigen elimination by maternal antibodies on the suppression of the offspring.

In the offspring of sheep erythrocyte (SRBC)- or chicken erythrocyte (CRBC)-immunized mothers, generation of cytotoxicity and plaque forming cells (PFC) were suppressed, while delayed-type hypersensitivity (DTH) was not. We performed experiments to analyse the mechanism of this suppression. Antigen specific antibodies, which enhanced opsonization or antibody-dependent cell-mediated cytotoxicity (ADCC), might have a close relation to the suppression (1). The suppression was weakened by a high-dose of antigen challenge or macrophage blockade with colloidal carbon, while enhanced by macrophage activation with Corynebacterium parvum. In contrast, secondary immune responses in the offspring showed the same amplitude as in normal mice. Therefore, the suppression in the offspring might be a result from the early antigen elimination by enhanced opsonization or ADCC due to passive antibodies. But, generation of memory cells or effector cells of DTH might not be affected in the presence of passively transferred antibodies.

Animals↗
PubMed1985

Natural cytostatic cells have a broader range of antitumor activity than natural killer cells.

Natural cytotoxic activity by Thy-1 negative, asialo-GM-1 positive and column-nonadherent spleen cells was detected against YAC-1 target cells but not against Meth-A and EL-4 target cells as reported by many investigators. In the present study, on the other hand, natural cytostatic activity was detected in Thy-1 negative, asialo-GM-1 negative and column-nonadherent cells and this activity was effective against YAC-1, Meth-A and EL-4 target cells. Such a cytostatic activity was not modified by the functional levels of T cells in the donor mice of effector cells. The cytostatic activity against Meth-A and EL-4 target cells was detected not only in an allogeneic system but also in a syngeneic system. The cytostatic activity was not depressed in a tumor-bearing state in contrast to the NK activity. The cytostatic activity as well as the NK activity was detected in spleen and peritoneal cells but not in lymph node cells of the various sources. The spleen and peritoneal cavity may play a role distinct from that of lymph nodes in the resistance against tumor development.

Animals↗
PubMed1985

[Recent trends in cardiac surgery for acquired heart disease].

Some recently developed problems in cardiac surgery for acquired heart diseases, in our department, have been discussed in this paper. Ischemic heart disease (IHD): Indication for aortocoronary bypass grafting (ACBG) has been extended for the patients with poor left ventricular function. The number of the patients, who are found to have IHD before general surgery have been increased. Surgical treatments for these patients, five with malignant tumor, and two with aneurysm of the descending aorta, were performed 16 days to 4 months after ACBG without any operative death. In three patients with lesions of carotid arteries, blood flow of the carotid arteries was monitored with doppler echography, which was found useful for this purpose, during extracorporeal circulation. One hundred and four patients, over 40 years old, for valvular surgery, had coronary angiography at the cardiac catheterization between 1982-1983. Nine patients (8%) had significant IHD. They had ACBG and valvular surgery simultaneously. Valvular heart disease (VHD): Long-term results following aortic valve replacement have showed that 6 deaths were of cardiac origin. Five of them were with poor preoperative left ventricular function (ejection fraction: 0.35 or less, left ventricular endsystolic volume index: 200 ml/m2 or more) which might be indices for indication of surgical treatment for aortic regurgitation.

Aged↗
PubMed1985

YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.

Two H-2 negative variants of the YAC-1 lymphoma were selected by mutagenization and sequential in vitro selections and compared with wild-type cells for changes in NK sensitivity and H-2 expression after interferon treatment or in vivo passage. The H-2 negative variants and the low H-2 expressor YAC-1 wild-type cells had similar NK sensitivity. However, IFN-beta or recombinant IFN-gamma pretreatments increased the H-2 expression of YAC-1 and protected them from NK lysis, whereas the H-2 variants, which remained H-2 negative, were not protected and often more sensitive to NK lysis. The H-2 variants were similarly susceptible as wild-type cells to three other cellular effects of interferon: protection from virus infection, modulation of Con A capping, and inhibition of cell proliferation. Thus, the only interferon-mediated effect that distinguished the H-2 negative variants from wild-type cells was the inability of the former to increase their H-2 expression and decrease their NK sensitivity. The wild-type YAC-1 line showed increased H-2 expression and decreased NK sensitivity after in vivo passage. In contrast, in vivo passaged H-2 variants showed no reexpression of H-2, and remained NK sensitive. The altered responses to interferon and in vivo passage were specific for loss or down-regulation of H-2, because Thy-1 loss (H-2 positive) YAC-1 variants behaved as the wild-type cells in all respects. This study supports the hypothesis that NK cells may function in vivo to eliminate host cells that fail to express H-2 after interferon stimulation during an immune response; such cells are a potential threat because they may escape recognition by T lymphocytes despite the expression of viral or tumor-associated antigens.

Animals↗
PubMed1985

Clinical evaluation of urapidil, a new antihypertensive drug: preliminary findings in Japan.

The pharmacokinetics, hypotensive effects, and safety of urapidil were investigated in 22 patients with essential hypertension at four coordinated centers in Japan. The drug was administered in sustained-release capsules given twice daily. The peak plasma concentration of the drug (measured in six patients) was observed four to six hours after administration, and 60% to 70% of the peak concentration was detectable at eight hours. These findings suggest that blood pressure might be controlled by twice-daily administration of urapidil. In 14 outpatients, who received 40 to 80 mg/day of urapidil, systolic and mean blood pressure decreased significantly (P less than 0.05) by week 4, and systolic, diastolic, and mean blood pressure decreased significantly (P less than 0.001) by week 6. In four inpatients, treated with 60 to 120 mg/day of the drug for two weeks, there were significant decreases (P less than 0.05) in systolic, diastolic, and mean blood pressure at day 6 and significant decreases (P less than 0.01) in diastolic and mean blood pressure at day 13. Although side effects were noted in five (23%) of the 22 patients, they were transient and slight in three; in two patients, the side effects disappeared after use of the medication was discontinued. Because the study was carried out in a small number of patients who received different dosages of urapidil over a short period of time, the optimal dosage was not established.

Adult↗